Low-energy DC current ablation in a mouse tumor model.

Area of Science:

• Oncology
• Biomedical Engineering
• Surgical Innovation

Background:

• Irreversible electroporation (IRE) is an emerging technique for tissue and tumor ablation.
• Developing effective animal models is crucial for optimizing novel therapeutic parameters.

Purpose of the Study:

• To establish and evaluate an animal model for optimizing irreversible electroporation parameters in subcutaneous tumor ablation.
• To assess the efficacy of IRE using the NanoKnife device in a preclinical setting.

Main Methods:

• Utilized the immortalized Panc1 tumor cell line for subcutaneous tumor induction in mice.
• Administered general anesthesia and muscle relaxation prior to electroporation.
• Employed the NanoKnife device for irreversible electroporation treatment.
• Monitored tumor response at predetermined intervals post-procedure.

Main Results:

• Successfully established a subcutaneous tumor model in mice for IRE studies.
• Demonstrated the feasibility of using the NanoKnife device for tumor ablation in this model.
• Collected data on tumor response to IRE for parameter optimization (specific results pending further analysis).

Conclusions:

• The developed animal model provides a platform for investigating optimal parameters for irreversible electroporation in subcutaneous tumor ablation.
• Further studies are warranted to fully elucidate the efficacy and refine treatment protocols for IRE in oncology.